140 related articles for article (PubMed ID: 1477486)
1. The administration of psychotropic and anticonvulsant drugs to children with profound intellectual disability and multiple impairments.
Hogg J
J Intellect Disabil Res; 1992 Dec; 36 ( Pt 6)():473-88. PubMed ID: 1477486
[TBL] [Abstract][Full Text] [Related]
2. Psychotropic drugs and mental retardation: 1. Disabilities and the prescription of drugs for behaviour and for epilepsy in three residential settings.
Clarke DJ; Kelley S; Thinn K; Corbett JA
J Ment Defic Res; 1990 Oct; 34 ( Pt 5)():385-95. PubMed ID: 2266549
[TBL] [Abstract][Full Text] [Related]
3. City-wide survey of drug patterns among non-institutionalized mentally retarded persons.
Aman MG; Field CJ; Bridgman GD
Appl Res Ment Retard; 1985; 6(2):159-71. PubMed ID: 4015083
[TBL] [Abstract][Full Text] [Related]
4. Antiepileptic drugs with mood stabilizing properties and their relation with psychotropic drug use in institutionalized epilepsy patients with intellectual disability.
Leunissen CL; de la Parra NM; Tan IY; Rentmeester TW; Vader CI; Veendrick-Meekes MJ; Aldenkamp AP
Res Dev Disabil; 2011; 32(6):2660-8. PubMed ID: 21752594
[TBL] [Abstract][Full Text] [Related]
5. Antiepileptic polypharmacy, psychosocial behaviour and locus of control orientation among mentally handicapped adults living in the community.
Espie CA; Gillies JB; Montgomery JM
J Ment Defic Res; 1990 Aug; 34 ( Pt 4)():351-60. PubMed ID: 2398491
[TBL] [Abstract][Full Text] [Related]
6. Comparison of community and institutional prescription of antiepileptic drugs for individuals with learning disabilities.
Branford D; Collacott RA
J Intellect Disabil Res; 1994 Dec; 38 ( Pt 6)():561-6. PubMed ID: 7881227
[TBL] [Abstract][Full Text] [Related]
7. Prevalence and patterns of psychotropic and anticonvulsant medication use in children and adolescents referred to residential treatment.
Connor DF; Ozbayrak KR; Harrison RJ; Melloni RH
J Child Adolesc Psychopharmacol; 1998; 8(1):27-38. PubMed ID: 9639077
[TBL] [Abstract][Full Text] [Related]
8. Psychopharmacoepidemiology of mental retardation: 1966 to 1995.
Singh NN; Ellis CR; Wechsler H
J Child Adolesc Psychopharmacol; 1997; 7(4):255-66. PubMed ID: 9542696
[TBL] [Abstract][Full Text] [Related]
9. Psychotropic drugs and mental retardation: 2. A comparison of psychoactive drug use before and after discharge from hospital to community.
Thinn K; Clarke DJ; Corbett JA
J Ment Defic Res; 1990 Oct; 34 ( Pt 5)():397-407. PubMed ID: 1979993
[TBL] [Abstract][Full Text] [Related]
10. A national study of prescribed drugs in institutions and community residential facilities for mentally retarded people.
Hill BK; Balow EA; Bruininks RH
Psychopharmacol Bull; 1985; 21(2):279-84. PubMed ID: 4001292
[TBL] [Abstract][Full Text] [Related]
11. Psychotropic and anticonvulsant drug use by mentally retarded adults across community residential and vocational placements.
Martin JE; Agran M
Appl Res Ment Retard; 1985; 6(1):33-49. PubMed ID: 2859836
[TBL] [Abstract][Full Text] [Related]
12. Prevalence and characteristics of psychotropic drug use in institutionalized children and adolescents with mild intellectual disability.
Scheifes A; de Jong D; Stolker JJ; Nijman HL; Egberts TC; Heerdink ER
Res Dev Disabil; 2013 Oct; 34(10):3159-67. PubMed ID: 23886758
[TBL] [Abstract][Full Text] [Related]
13. Psychiatric comedication in patients with epilepsy.
Bosak M; Cyranka K; Dudek D; Kowalik M; Mołek P; Słowik A
Epilepsy Behav; 2018 Jun; 83():207-211. PubMed ID: 29706306
[TBL] [Abstract][Full Text] [Related]
14. Monitoring drugs in hospitals for the mentally handicapped.
James DH
Br J Psychiatry; 1983 Feb; 142():163-5. PubMed ID: 6839070
[No Abstract] [Full Text] [Related]
15. Aggressive behaviour in intellectually challenged patients with epilepsy treated with lamotrigine.
Beran RG; Gibson RJ
Epilepsia; 1998 Mar; 39(3):280-2. PubMed ID: 9578045
[TBL] [Abstract][Full Text] [Related]
16. Adverse events and the relation with quality of life in adults with intellectual disability and challenging behaviour using psychotropic drugs.
Scheifes A; Walraven S; Stolker JJ; Nijman HL; Egberts TC; Heerdink ER
Res Dev Disabil; 2016; 49-50():13-21. PubMed ID: 26647003
[TBL] [Abstract][Full Text] [Related]
17. Psychotropic and anticonvulsant drugs in subjects with autism: prevalence and patterns of use.
Aman MG; Van Bourgondien ME; Wolford PL; Sarphare G
J Am Acad Child Adolesc Psychiatry; 1995 Dec; 34(12):1672-81. PubMed ID: 8543539
[TBL] [Abstract][Full Text] [Related]
18. Antiepileptic drugs, occurrence of seizures and effect of co-administration of potential seizure threshold-lowering psychotropic drugs in adults with intellectual disability who have epilepsy.
Monaghan R; O'Dwyer M; Luus R; Mulryan N; McCallion P; McCarron M; Henman MC
J Appl Res Intellect Disabil; 2021 May; 34(3):818-829. PubMed ID: 33530136
[TBL] [Abstract][Full Text] [Related]
19. Psychotropic drug prescribing in child and adolescent learning disability psychiatry.
Bramble D
J Psychopharmacol; 2007 Jul; 21(5):486-91. PubMed ID: 17446203
[TBL] [Abstract][Full Text] [Related]
20. Problem behavior and psychiatric impairment within a developmentally disabled population. III: Psychotropic medication.
Jacobson JW
Res Dev Disabil; 1988; 9(1):23-38. PubMed ID: 3353539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
